Lesley Outlaw
Gerontology · Dublin, GANPI 1659157303
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,797 and has fallen 59.8% since, to $722 in 2025.
Across 120 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$457
- Merck$335
- AstraZeneca$231
- Lilly USA, LLC$173
- Seagen Inc.$99
- Exelixis Inc.$96
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,49393%
- Education$1877%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $457 |
| Merck | 14 | $335 |
| AstraZeneca(2 entities) | 11 | $231 |
| Lilly USA, LLC | 8 | $173 |
| Seagen Inc. | 1 | $99 |
| Exelixis Inc. | 5 | $96 |
| Johnson & Johnson(2 entities) | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| Daiichi Sankyo Inc. | 3 | $84 |
| Bayer | 4 | $78 |
| Beigene USA, Inc. | 3 | $77 |
| Bristol Myers Squibb | 3 | $72 |
| Gilead | 3 | $64 |
| AVEO Pharmaceuticals, Inc. | 2 | $62 |
| Genentech USA, Inc. | 3 | $60 |
| Jazz Pharmaceuticals Inc. | 2 | $54 |
| Sobi, Inc | 3 | $50 |
| Sanofi | 2 | $49 |
| Incyte Corporation | 2 | $40 |
| Eisai Inc. | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 2 | $34 |
| GSK | 2 | $33 |
| Astellas Pharma US Inc | 2 | $33 |
| Array Biopharma Inc | 2 | $33 |
| AbbVie | 1 | $29 |
| Taiho Oncology, Inc. | 1 | $27 |
| Novo Nordisk | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $23 |
| Novartis | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Mirati Therapeutics, Inc. | 1 | $14 |
| Genmab U.S., Inc. | 1 | $14 |
How this compares
$2,680 in reported general payments places this provider in the 80th percentile of 197 gerontology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Dublin
- Carolyn ClevengerAtlanta$65K
- Mitzi LewisAtlanta$37K
- Constance MeinkenAtlanta$36K
- Britni JohnsonSavannah$24K
- Doreen AbrigoWarner Robins$14K
- Taylor SwineaWaycross$10K
- Michelle DudleyMacon$10K
- Kathleen BradfordAtlanta$8K
- Teresa VickersWarner Robins$6K
- Melissa RusterucciPeachtree City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.